Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
393.3 USD | -0.21% | -1.09% | -3.35% |
07:01pm | UBS Adjusts Vertex Pharmaceuticals Price Target to $466 From $498, Maintains Buy Rating | MT |
02:36pm | Guggenheim Adjusts Vertex Pharmaceuticals' Price Target to $450 From $445 | MT |
Filters
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated